↓ Skip to main content

On the prediction of Hodgkin lymphoma treatment response

Overview of attention for article published in Clinical and Translational Oncology, April 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
35 Mendeley
Title
On the prediction of Hodgkin lymphoma treatment response
Published in
Clinical and Translational Oncology, April 2015
DOI 10.1007/s12094-015-1285-z
Pubmed ID
Authors

E. J. deAndrés-Galiana, J. L. Fernández-Martínez, O. Luaces, J. J. del Coz, R. Fernández, J. Solano, E. A. Nogués, Y. Zanabilli, J. M. Alonso, A. R. Payer, J. M. Vicente, J. Medina, F. Taboada, M. Vargas, C. Alarcón, M. Morán, A. González-Ordóñez, M. A. Palicio, S. Ortiz, C. Chamorro, S. Gonzalez, A. P. González-Rodríguez

Abstract

The cure rate in Hodgkin lymphoma is high, but the response along with treatment is still unpredictable and highly variable among patients. Detecting those patients who do not respond to treatment at early stages could bring improvements in their treatment. This research tries to identify the main biological prognostic variables currently gathered at diagnosis and design a simple machine learning methodology to help physicians improve the treatment response assessment. We carried out a retrospective analysis of the response to treatment of a cohort of 263 Caucasians who were diagnosed with Hodgkin lymphoma in Asturias (Spain). For that purpose, we used a list of 35 clinical and biological variables that are currently measured at diagnosis before any treatment begins. To establish the list of most discriminatory prognostic variables for treatment response, we designed a machine learning approach based on two different feature selection methods (Fisher's ratio and maximum percentile distance) and backwards recursive feature elimination using a nearest-neighbor classifier (k-NN). The weights of the k-NN classifier were optimized using different terms of the confusion matrix (true- and false-positive rates) to minimize risk in the decisions. We found that the optimum strategy to predict treatment response in Hodgkin lymphoma consists in solving two different binary classification problems, discriminating first if the patient is in progressive disease; if not, then discerning among complete and partial remission. Serum ferritin turned to be the most discriminatory variable in predicting treatment response, followed by alanine aminotransferase and alkaline phosphatase. The importance of these prognostic variables suggests a close relationship between inflammation, iron overload, liver damage and the extension of the disease.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 35 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 11%
Student > Postgraduate 3 9%
Professor > Associate Professor 3 9%
Student > Doctoral Student 3 9%
Student > Bachelor 2 6%
Other 10 29%
Unknown 10 29%
Readers by discipline Count As %
Medicine and Dentistry 6 17%
Psychology 3 9%
Computer Science 3 9%
Social Sciences 2 6%
Agricultural and Biological Sciences 1 3%
Other 6 17%
Unknown 14 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 July 2015.
All research outputs
#18,418,694
of 22,816,807 outputs
Outputs from Clinical and Translational Oncology
#845
of 1,304 outputs
Outputs of similar age
#193,449
of 265,321 outputs
Outputs of similar age from Clinical and Translational Oncology
#10
of 17 outputs
Altmetric has tracked 22,816,807 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,304 research outputs from this source. They receive a mean Attention Score of 3.7. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 265,321 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.